Tyrosine Kinase
Tyrosine Kinase(酪氨酸激酶)
- Bcr-Abl(73)
- Ack1(3)
- Axl(6)
- ALK(64)
- BMX Kinase(3)
- Broad Spectrum Protein Kinase Inhibitor(10)
- c-FMS(42)
- c-Kit(58)
- c-MET(99)
- c-RET(7)
- CSF-1R(3)
- DDR1/DDR2 Receptor(1)
- EGFR(278)
- EphB4(1)
- FAK(39)
- FGFR(104)
- FLT3(97)
- HER2(15)
- IGF1R(34)
- Insulin Receptor(46)
- IRAK(32)
- ITK(10)
- Lck(1)
- LRRK2(25)
- PDGFR(113)
- PTKs/RTKs(10)
- Pyk2(8)
- ROR(41)
- Spleen Tyrosine Kinase (Syk)(33)
- Src(108)
- Tie-2 (4)
- Trk(43)
- VEGFR(200)
- Kinase
- Discoidin Domain Receptor(16)
- DYRK(35)
- Ephrin Receptor(13)
- RET(30)
- ROS(14)
- TAM Receptor(33)
- IGFBR(1)
- Others(55)
Tyrosine Kinase 相关产品(1402)
- GP26187ErbB4 Human
ErbB4 Human Recombinant produced in HEK293 Cells is a single, glycosylated polypeptide chain containing 863 amino acids (26-649 a
- GP26200TYRO3 Mouse
TYRO3 Mouse produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 628 amino acids (31-419 aa) and having a molecular mass of 68
- GC11126Mutant EGFR inhibitorCAS: 1421373-62-7纯度: >99.00%
Mutant EGFR inhibitor 是从专利WO 2013014448 A1中提取的一种有效的选择性突变EGFR抑制剂;抑制 EGFRL858R、EGFRExon 19 缺失和 EGFRT790M。
- GC13854AG-490 (Tyrphostin B42)CAS: 133550-30-8纯度: >98.00%
AG-490 (Tyrphostin B42)是EGFR抑制剂,IC50为0.1 µM, AG-490对JAK2也有抑制作用。
- GC11044Fostamatinib (R788)CAS: 901119-35-5纯度: >98.50% / >98.00%
Fostamatinib (R788) 是活性化合物 R406 的口服前药,R406 是一种相对选择性的 Syk 小分子抑制剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GN10737 | Tanshinone IIA | 568-72-9 | >99.50% | |
Tanshinone IIA 是一种从丹参中分离出来的主要丹参酮,常用于心血管疾病和癌症的研究。 | ||||
| GN10784 | Rhoifolin | 17306-46-6 | >98.00% | |
A flavonoid glycoside with diverse biological activities | ||||
| GP26187 | ErbB4 Human | - | - | |
ErbB4 Human Recombinant produced in HEK293 Cells is a single, glycosylated polypeptide chain containing 863 amino acids (26-649 a | ||||
| GP26200 | TYRO3 Mouse | - | - | |
TYRO3 Mouse produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 628 amino acids (31-419 aa) and having a molecular mass of 68 | ||||
| GC10627 | Erlotinib | 183321-74-6 | >99.50% / >98.00% | |
Erlotinib是一种有效且口服生物可利用的表皮生长因子受体(EGFR)酪氨酸激酶抑制剂,IC 50 值为2 nM。 | ||||
| GC10944 | Butein | 487-52-5 | >98.00% | |
A plant polyphenol | ||||
| GC11126 | Mutant EGFR inhibitor | 1421373-62-7 | >99.00% | |
Mutant EGFR inhibitor 是从专利WO 2013014448 A1中提取的一种有效的选择性突变EGFR抑制剂;抑制 EGFRL858R、EGFRExon 19 缺失和 EGFRT790M。 | ||||
| GC11691 | AST-1306 | 897383-62-9 | - | |
An irreversible inhibitor of EGFR, HER2, and HER4 | ||||
| GC11696 | 1-NM-PP1 | 221244-14-0 | >99.50% | |
Inhibitor of modified 'analog-sensitive' kinases | ||||
| GC12478 | ARRY-380 | 937265-83-3 | - | |
An inhibitor of EGFR | ||||
| GC13738 | SKLB1002 | 1225451-84-2 | - | |
A VEGFR2 inhibitor | ||||
| GC13854 | AG-490 (Tyrphostin B42) | 133550-30-8 | >98.00% | |
AG-490 (Tyrphostin B42)是EGFR抑制剂,IC50为0.1 µM, AG-490对JAK2也有抑制作用。 | ||||
| GC13868 | GNE-9605 | 1536200-31-3 | >99.50% | |
A potent LRRK2 inhibitor | ||||
| GC14288 | KX2-391 | 897016-82-9 | >99.00% | |
A Src kinase inhibitor | ||||
| GC14310 | NVP-ADW742 | 475488-23-4 | >99.00% | |
An IGF-1R inhibitor | ||||
| GC14695 | CO-1686 (AVL-301) | 1374640-70-6 | >99.50% | |
A selective inhibitor of mutant EGFR | ||||
| GC15669 | AST-1306 TsOH | 1050500-29-2 | >99.50% | |
An irreversible inhibitor of EGFR, HER2, and HER4 | ||||
| GC16698 | AZD-9291 mesylate | 1421373-66-1 | >99.50% | |
An inhibitor of mutant EGFR | ||||
| GC17530 | OSI-420 | 183320-51-6 | >98.50% | |
OSI-420 (OSI-420) 是厄洛替尼的活性代谢物。厄洛替尼是一种有效的 EGFR 酪氨酸激酶抑制剂。 | ||||
| GC17647 | AG-18 | 118409-57-7 | >98.50% | |
An inhibitor of EGF receptor kinase | ||||
| GC17982 | Icotinib | 610798-31-7 | >99.00% / >99.50% | |
Icotinib表皮生长因子受体(EGFR;IC 50 =5nM)抑制剂,可抑制EGFR(L858R,T790M,L861Q)等突变体。 | ||||
| GC11044 | Fostamatinib (R788) | 901119-35-5 | >98.50% / >98.00% | |
Fostamatinib (R788) 是活性化合物 R406 的口服前药,R406 是一种相对选择性的 Syk 小分子抑制剂。 | ||||
| GC14464 | Vatalanib | 212141-54-3 | - | |
A potent and selective VEGF receptor inhibitor | ||||
| GC17789 | A 419259 trihydrochloride | 1435934-25-0 | >99.00% | |
An inhibitor of Src family kinases | ||||
